Literature DB >> 6090351

HLA loss variants of a B27+ lymphoblastoid cell line: genetic and cellular characterization.

J A Nicklas, Y Miyachi, J D Taurog, S L Wee, L K Chen, F C Grumet, F H Bach.   

Abstract

Variants of a lymphoblastoid cell line, LCL 526 (SB3 MB1 DR1 B44 C5 A2/SB4 MT4 DR4 B27 C2 A24), which lost various HLA specificities were selected with monoclonal antibodies and complement using a method developed by Kavathas et al. (PNAS 77:4251, 1980). Using alpha B27 monoclonals, 8 B27 only loss mutants and 4 B27 haplotype multiple loss mutants were generated. The parental LCL 526 and two of the B27- mutants were used to select alpha B27 CTLs. The selection of six A2 loss, one A2-C5 loss, and 14 A2 haplotype multiple loss variants as well as secondary selection on haplotype loss variants to obtain A null, B null, DR null, and total A, B, C, null variants is also described. The usefulness of these mutants for the study of the relationship between B27 and disease and as two new haplotypes for immunologic, genetic, and molecular research is discussed. These mutants are available to other researchers.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090351     DOI: 10.1016/0198-8859(84)90053-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria.

Authors:  D H Kono; M Ogasawara; R B Effros; M S Park; R L Waldord; D T Yu
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

2.  Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cells.

Authors:  J H Hanke; R G Cook; J W Leone; M Van; R R Rich
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.